Dr. Rubina Ehtesham, MD

Dr. Ehtesham practices at Javon Bea Hospital in Rockford, Illinois.

Dr. Ehtesham's NPI, 1962512152, was assigned on August 30, 2006. Dr. Ehtesham holds Illinois license 036103553.

Dr. Ehtesham's primary practice is Javon Bea Hospital, at 8201 E Riverside Blvd, Rockford, IL 61114 in Winnebago County. The practice phone is (815) 971-5000.

Dr. Ehtesham's primary practice is Javon Bea Hospital in Rockford, Illinois. Dr. Ehtesham is also affiliated with Javon Bea Hospital-Riverside. The medical group on file is Mercyhealth Physicians. Dmand AI also links Dr. Ehtesham to 1 more skilled nursing facility, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ehtesham practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ehtesham's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ehtesham is licensed in Illinois.

CMS data shows 488 Medicare services from Dr. Ehtesham across 5 procedure codes in 2024, for 177 Medicare patients. Medicare paid $37,058 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 177 Medicare patients who saw Dr. Ehtesham in 2024. The largest group is 75 to 84, with 57 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ehtesham's median patient age at 73, with 58% women.

In 2024, Dr. Ehtesham wrote 324 Medicare Part D claims for 120 patients. 85% of them were for generic drugs. CMS names the drug for 113 of them, across 7 drugs with 11 or more claims each, at $433 in total drug cost. In 2023, CMS named 115 claims across 8 drugs.

Dr. Ehtesham accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 124 general payments to Dr. Ehtesham from 23 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $406.